Menu
Back to User profile » Dr Kongming Wu
Papers published by Dr Kongming Wu:
Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
Bai X, Yi M, Jiao Y, Chu Q, Wu K
OncoTargets and Therapy 2019, 12:9527-9538
Published Date: 11 November 2019
The regulation of cytokine signaling by retinal determination gene network pathway in cancer
Zheng X, Liu Q, Yi M, Qin S, Wu K
OncoTargets and Therapy 2018, 11:6479-6487
Published Date: 4 October 2018
Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
Bai X, Yi M, Xia X, Yu S, Zheng X, Wu K
Cancer Management and Research 2018, 10:4039-4050
Published Date: 28 September 2018
The clinical significance of CXCL5 in non-small cell lung cancer
Wu K, Yu S, Liu Q, Bai X, Zheng X, Wu K
OncoTargets and Therapy 2017, 10:5561-5573
Published Date: 21 November 2017
A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
Yuan X, Ji W, Chen S, Bao Y, Tan S, Lu S, Wu K, Chu Q
International Journal of Nanomedicine 2016, 11:2119-2131
Published Date: 25 May 2016
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
Xu HX, Tian YJ, Yuan X, Liu Y, Wu H, Liu Q, Wu GS, Wu KM
OncoTargets and Therapy 2016, 9:431-444
Published Date: 21 January 2016
The role of CD44 in epithelial–mesenchymal transition and cancer development
Xu HX, Tian YJ, Yuan X, Wu H, Liu Q, Pestell RG, Wu KM
OncoTargets and Therapy 2015, 8:3783-3792
Published Date: 16 December 2015